TIDEA™ * is a target-independent approach to prediction of small molecule drug candidate affinity for biological targets that is effective for multiple targets, molecular shapes and scaffolds. It is a unique in silico application that can be used to select molecules with high affinity without sacrificing structural diversity.
TIDEA™ differs from ligand-based approaches because it
TIDEA™ can be used in early stage screening prior to application of target-specific methods and/or when the target is unknown or 3D structure or SAR data are not available. Unlike target-specific approaches, TIDEA™ can be used to discover new drug candidates for complex, multi-target disease states.
Utilize TIDEA™ to help you
* Target-Independent Drug Enhancement Algorithm
Contact us to learn more and gain access to TIDEA™
Browse our online catalog for TIDEA™ screening compounds